Arrivent Biopharma Inc (AVBP)

Dec 19, 2024

(AVBP) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Dec 19, 2024

Dec 15, 2024

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Short Interest Up 6.1% in November - MarketBeat

Dec 15, 2024

Dec 14, 2024

Charles Schwab Investment Management Inc. Buys 122,641 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Dec 14, 2024

Dec 14, 2024

BNP Paribas Financial Markets Raises Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Dec 14, 2024

Dec 14, 2024

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by Charles Schwab Investment Management Inc. - MarketBeat

Dec 14, 2024

Dec 09, 2024

(AVBP) Investment Analysis - Stock Traders Daily

Dec 09, 2024

Dec 08, 2024

Fmr LLC Purchases 169,514 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - MarketBeat

Dec 08, 2024

Dec 05, 2024

Suvretta Capital Management, LLC Acquires Additional Shares in A - GuruFocus.com

Dec 05, 2024

Dec 01, 2024

Short Interest in ArriVent BioPharma, Inc. (NASDAQ:AVBP) Decreases By 11.9% - MarketBeat

Dec 01, 2024

Nov 29, 2024

Suvretta Capital Management LLC Purchases 132,459 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - MarketBeat

Nov 29, 2024

Nov 28, 2024

(AVBP) Trading Report - Stock Traders Daily

Nov 28, 2024

Nov 17, 2024

ArriVent BioPharma Reports Advancements and Q3 2024 Financial Results - MSN

Nov 17, 2024

Nov 17, 2024

Where are the Opportunities in (AVBP) - Stock Traders Daily

Nov 17, 2024

Nov 16, 2024

ArriVent Biopharma Inc (AVBP) Stock Price & Chart | Trade Now - Capital.com

Nov 16, 2024

Nov 15, 2024

ArriVent BioPharma (NASDAQ:AVBP) Receives Buy Rating from HC Wainwright - MarketBeat

Nov 15, 2024

Nov 14, 2024

ArriVent BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024

Nov 14, 2024

ArriVent BioPharma Reports Third Quarter 2024 Financial Results - The Bakersfield Californian

Nov 14, 2024

Nov 14, 2024

ArriVent Reports $282.9M Cash Position, Firmonertinib Shows Promise in NSCLC Trial | AVBP Stock News - StockTitan

Nov 14, 2024

Nov 13, 2024

FMR LLC's Strategic Acquisition of ArriVent BioPharma Inc Shares - GuruFocus.com

Nov 13, 2024

Nov 07, 2024

(AVBP) On The My Stocks Page - Stock Traders Daily

Nov 07, 2024

Nov 06, 2024

Discover the 3 Best-Performing Biotech IPO Stocks of 2024 - MSN

Nov 06, 2024

Nov 05, 2024

AlphaCentric Advisors LLC Cuts Stock Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - MarketBeat

Nov 05, 2024

Oct 27, 2024

Long Term Trading Analysis for (AVBP) - Stock Traders Daily

Oct 27, 2024

Oct 25, 2024

ArriVent BioPharma Reports Strong Second Quarter and Highlights Progress - MSN

Oct 25, 2024

Oct 24, 2024

ArriVent BioPharma (NASDAQ:AVBP) Reaches New 12-Month HighShould You Buy? - MarketBeat

Oct 24, 2024

Oct 19, 2024

ArriVent To Present FURTHER Data At The 2024 World Conference On Lung Cancer - RTTNews

Oct 19, 2024

Oct 16, 2024

When the Price of (AVBP) Talks, People Listen - Stock Traders Daily

Oct 16, 2024

Oct 12, 2024

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Short Interest Up 80.1% in September - MarketBeat

Oct 12, 2024

Oct 11, 2024

Octagon Capital Advisors LP Increases Stake in ArriVent BioPharma Inc - Yahoo Finance

Oct 11, 2024

Oct 06, 2024

(AVBP) Proactive Strategies - Stock Traders Daily

Oct 06, 2024

Oct 03, 2024

ArriVent BioPharma (NASDAQ:AVBP) Shares Up 6.3% - MarketBeat

Oct 03, 2024

Sep 30, 2024

Novo Holdings A S Buys 422,860 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - MarketBeat

Sep 30, 2024

Sep 29, 2024

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Short Interest Up 13.4% in September - MarketBeat

Sep 29, 2024

Sep 29, 2024

Short Interest in ArriVent BioPharma, Inc. (NASDAQ:AVBP) Rises By 13.4% - MarketBeat

Sep 29, 2024

Sep 28, 2024

Regeneron purchases former Quad Graphics site in Saratoga Springs - MSN

Sep 28, 2024

Sep 25, 2024

How to Take Advantage of moves in (AVBP) - Stock Traders Daily

Sep 25, 2024

Sep 24, 2024

We Think ArriVent BioPharma (NASDAQ:AVBP) Can Afford To Drive Business Growth - Simply Wall St

Sep 24, 2024

Sep 24, 2024

Bank of New York Mellon Corp Grows Stake in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Sep 24, 2024

Sep 23, 2024

ArriVent BioPharma (NASDAQ:AVBP) Stock Price Down 5.6% - MarketBeat

Sep 23, 2024

Sep 23, 2024

It makes sense and dollars to buy ArriVent BioPharma Inc. (AVBP) stock - SETE News

Sep 23, 2024

Sep 22, 2024

ArriVent BioPharma, Inc.(NasdaqGM:AVBP) added to S&P Biotechnology Select Industry Index - Marketscreener.com

Sep 22, 2024

Sep 20, 2024

ArriVent BioPharma (NASDAQ:AVBP) Shares Gap Down to $23.94 - Defense World

Sep 20, 2024

Sep 20, 2024

Was ArriVent BioPharma Inc. (AVBP)’s session last reading good? - US Post News

Sep 20, 2024

Sep 20, 2024

Closing Figures: ArriVent BioPharma Inc. (AVBP)’s Positive Finish at 24.20, Up 2.59 - The Dwinnex

Sep 20, 2024

Sep 17, 2024

ArriVent BioPharma: Bringing A Novel Cancer Drug From China (NASDAQ:AVBP) - Seeking Alpha

Sep 17, 2024

Sep 12, 2024

ArriVent BioPharma (NASDAQ:AVBP) Price Target Increased to $36.00 by Analysts at Citigroup - Defense World

Sep 12, 2024

Sep 12, 2024

Citigroup Raises ArriVent BioPharma (NASDAQ:AVBP) Price Target to $36.00 - MarketBeat

Sep 12, 2024

Sep 11, 2024

ArriVent Targets PACC Mutation Market With EGFR TKI Firmonertinib In Lung Cancer - Scrip

Sep 11, 2024

Sep 11, 2024

ArriVent BioPharma (NASDAQ:AVBP) Shares Down 4.3% - MarketBeat

Sep 11, 2024

Sep 11, 2024

Global economic uncertainty takes toll on China’s biotech ecosystem - BioWorld Online

Sep 11, 2024

Sep 11, 2024

ArriVent BioPharma Unveils Promising Phase 1b Data for Firmonertinib in Treating NSCLC - MyChesCo

Sep 11, 2024

Sep 11, 2024

ArriVent BioPharma (NASDAQ:AVBP) Given Outperform Rating at Oppenheimer - Defense World

Sep 11, 2024

Sep 11, 2024

ArriVent BioPharma (NASDAQ:AVBP) Shares Gap Up Following Analyst Upgrade - MarketBeat

Sep 11, 2024